Large-scale testing (Phase 3)Study completedNCT02214225
What this trial is testing
Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.
Who this might be right for
Influenza, Human
Seqirus 3,484